Scientific Sessions 2025  /  Heart Failure Management Across Kidney Stages: From CKD to ESRD and Transplant  /  Key Considerations for GDMT in Kidney Transplant Recipients
Logo

American Heart Association

  82
  0

Final ID:

Key Considerations for GDMT in Kidney Transplant Recipients

  • Tatapudi, Vasishta  ( NYU , New York , New York , United States )
  • Bali, Atul  ( Geisinger , Scranton , Pennsylvania , United States )
  • Birdwell, Kelly  ( VUMC , Nashville , Tennessee , United States )
  • Lentine, Krista  ( St. Louis University , St. Louis , Missouri , United States )
  • Cheng, Xingxing  ( Stanford University , Stanford , California , United States )
    • Author Disclosures:
    Vasishta Tatapudi: No Answer | Atul Bali: No Answer | Kelly Birdwell: DO NOT have relevant financial relationships | Krista Lentine: DO NOT have relevant financial relationships | Xingxing Cheng: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Heart Failure Management Across Kidney Stages: From CKD to ESRD and Transplant

Friday, 11/07/2025 , 04:00PM - 05:15PM

Cardiovascular Seminar

More abstracts on this topic:
Implementing Heart Failure GDMT in Advanced CKD: Key Considerations

Covic Adrian, Bali Atul, Testani Jeffrey, Tuttle Katherine, Bansal Nisha

The Evolution of Combined Heart-Kidney Transplantation

Agarwal Krishna, Naim Issa

More abstracts from these authors:
Implementing Heart Failure GDMT in Advanced CKD: Key Considerations

Covic Adrian, Bali Atul, Testani Jeffrey, Tuttle Katherine, Bansal Nisha

A 30yo with giant cell myocarditis is on VA ECMO for cardiogenic shock and developed renal failure requiring CVVH. The next best step is to proceed with heart transplant and consider safety-net kidney transplant if renal function does not improve.

Mccallum Wendy, Cheng Xingxing, Rangaswami Janani, Khazanie Prateeti

You have to be authorized to contact abstract author. Please, Login
Not Available